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Cell culture systems, either 2D or explant based, have been pivotal to better understand the
pathophysiology of several central nervous system (CNS) disorders. Recently, bioengineered cell culture
systems have been proposed as an alternative to the traditional setups. These innovative systems often
combine different cell populations in 3D environments that more closely recapitulate the different
niches that exist within the developing or adult CNS. Given the importance of such systems for the future
of CNS-related research, we discuss here the most recent advances in the field, particularly those dealing
with neurodegeneration, neurodevelopmental disorders, and trauma.Introduction
Injury and disease within the CNS frequently induce chronic and
acute insults leading to irreversible processes resulting in neuronal
cell death. This fact is intimately related to the low regenerative
potential of the CNS and the complexity of its several niches.
Additionally, the causes that induce such phenomena are multivar-
iate in nature. Indeed, cell death within the CNS can be triggered by
injury, as in traumatic brain injury (TBI) or spinal cord injury (SCI);
protein aggregation, such as in the case of Alzheimer’s (AD) or
Parkinson’s disease (PD); neurodevelopmental-related problems,
such as Rett syndrome; or induced neurodevelopmental neurotox-
icity (DNT) phenomena. Thus, understanding the mechanisms
behind such pathologies, as well as the possible therapeutic strate-
gies that could be used to counteract them, is essential. To do so, it is
essential to understand how CNS cells operate under these condi-
tions, as well as how they interact with each other.
Animal models of injury and disease, as well as CNS cell culture
systems, are often use to assess CNS cell interactions and how they
operate. Models of injury are often seen as the last phase of
preclinical research and try to replicate, as far as possible, thePlease cite this article in press as: Teixeira, D.T.D. et al. Bioengineered cell culture systems o
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http://dx.doi.org/10.1016/j.drudis.2016.04.020 molecular, biochemical, and phenotypical characteristics of the
CNS condition under study. However, for the initial screening of
therapies, such as a library of small molecules with potential
therapeutic use, such models might not be the best option. For
instance, the differences between animal and human cell biology
can lead to misleading results in important areas, such as toxicol-
ogy [1,2]. Models of disease have been also used for years to
understand the molecular mechanisms of injury and disease of
the CNS, as well as for the early development of therapeutic
strategies. Within these models, cell lines such as SH-SY5Y [3],
N2 [4] or PC-12 [5], or MO-4 [6] are commonly the first system to be
used. However the gold standard within the field are primary
cultures of CNS cells [neural stem cells (NSC), neurons, astrocytes,
oligodendrocytes, and microglial cells], which are often isolated
from embryonic or early postnatal [up to postnatal day (P)5] tissue
from rodents, mainly mice and rats [7]. Other popular systems
within the field are explant cultures [8] and organotypic-like
cultures [9–11]. Explant cultures are often used to study, for
example, the development of axons and processes associated with
it, whereas organotypic-like cultures are popular in the study of
how CNS cells work in a 3D environment, such as the spinal
cord [9], hippocampus [10] or substantia nigra/striatum [11].f central nervous system injury and disease, Drug Discov Today (2016), http://dx.doi.org/
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how CNS cells operate, the fact is that they have several limita-
tions. For instance, the primary tissue source for their isolation is
rodent tissue, either from embryonic or early postnatal origin,
which limits the extent of the studies that can be performed,
namely if the goal is to study the disease and/or injury on hu-
man-based cell culture models for translational purposes. More-
over, the culture systems themselves do not exactly recapitulate
the different niches of the CNS. For example, standard cell culture
systems are often 2D, whereas tissue structures are 3D, and are
limited to one or two cell types. In addition, both explant and
organotypic culture systems are limited in time (e.g. 2 weeks),
which is a disadvantage if the objective is to study protein aggre-
gation, and disease progression, for example.
To overcome these limitations, different bioengineered systems
have been proposed as reliable alternatives. Indeed, with the
advent of stem cell biology, biomaterials, microfluidics, and ro-
botics, new systems have been developed that more closely resem-
ble the CNS environment. Thus, here we describe and discuss the
most relevant and recent developments in this field (the most
relevant of which are summarized in Table 1), particularly those
related to brain barriers, neurodevelopmental disorders, differen-
tiation, neurodegeneration, and trauma.
Bioengineered systems in CNS injury and disease
Brain barriers
For CNS homeostasis, the existence of brain barriers is essential to
actively limit and regulate the passage of cells and molecules into,
and out of, the brain. Thus, the cells that constitute these barriers
function not only as gatekeepers, but also to secrete specific
molecules that influence brain physiology. The perturbation of
brain barriers has been found in many neurological disorders,
including those discussed here. Restoring the integrity of the
blood–brain barrier (BBB) in pathological conditions to maintain
brain homeostasis and, for instance, opening it temporarily to
allow the efficient delivery of drugs to the CNS, are potential
therapeutic options for patients with these disorders. Thus, the
development of BBB models that can mimic as far as possible the
environment observed in vivo are of the utmost interest in the field
of CNS regenerative medicine.
There are two main brain barriers: the BBB and the blood–
cerebrospinal fluid barrier (BCSFB). The meninges, which are also
barriers within the brain, are not considered here [12]. The BBB is
formed by the endothelial cells of blood capillaries, a basal lamina,
pericytes, the end-feet of astrocytes, and a few neuronal terminals
[13]. In turn, the main structure of the BCSFB is the choroid plexus
(CP), which is a small membrane suspended inside the space of the
CSF-filled brain ventricles. The key feature of the CP is a polarized
monolayer of epithelial cells separated by tight junctions, with
high secretory and/or transporter capacity; this layer separates the
periphery (blood-side) on its basolateral side from the CNS (CSF
side) on its apical side [14]. A well-recognized function of the CP is
the production of CSF, which in turn is affected by alterations that
occur in the CP epithelial cells [15]. Both the BBB and BCSFB are
involved in several disorders of the CNS, including AD, multiple
sclerosis (MS), and stroke, prompting the need to develop in vitro
cell culture systems that mimic the organization and functionality
of these barriers.Please cite this article in press as: Teixeira, D.T.D. et al. Bioengineered cell culture systems o
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2 www.drugdiscoverytoday.comIn vitro 2D cell culture systems of the brain barriers are based on
the principle of separation between two compartments, one that
simulates the blood side and the other the brain parenchyma side.
Separating these two compartments is a monolayer of endothelial
cells (BBB) or CP epithelial cells (BCSFB) seeded on top of a usually
porous filter, such as Transwell polycarbonate or polyethylene
inserts. The establishment of the barrier properties of this in vitro
model and, hence, of the absence of the paracellular passage of
molecules, compounds, or cells, must be confirmed by, for exam-
ple, the measurement of transendothelial (or epithelial) electrical
resistance (TEER). This two-chambered, single monolayer, system
is a less complex in vitro way of modeling the barriers in the brain.
Although such models have some limitations, they are relevant for
permeability screening, transport assays [16], and investigating
the transcellular passage of immune cells, among other uses
[17,18]. In the case of the BBB, co-culture and triple co-culture
systems have been added to the monocultures, introducing astro-
cytes and/or pericytes to these systems in addition to the endo-
thelial cells; although they better mimic the cellular organization
of the BBB, these later cell culture systems are complex in terms of
the culture medium conditions supplied to both compartments
(extensively reviewed in [16]). Given the specific polarized nature
of CP epithelial cells, with their apical side bathing the CSF, two-
compartment CP cultures are used to test the effects of blood- [15]
and brain parenchyma-derived molecules [19] on the barrier prop-
erties of the BCSFB.
Although the above cell culture systems have been extensively
used to study the interplay between the CNS and the periphery,
the need for further complex 3D culture systems that entirely
mimic both the BBB and the BCSFB still exists, especially for
human cells. A particular aspect in which bioengineered models
could provide added value compared with more traditional co-
culture models, is in the use of flow to modulate the behavior of
the cells. Indeed, shear stress, generated by the flow of blood under
physiological conditions affects transporter as well as endothelial
barrier function [20]. Endothelial cells and astrocytes are plated on
the inner (luminal) and outer (abluminal) sides of porous hollow
fibers, respectively, and the culture medium is then pumped into
the system via a variable-speed pump to generate shear stress
comparable with that seen in physiological conditions in vivo
[21]. To maintain the stable microenvironment, a gas-permeable
tubing system is used for the exchange of O2 and CO2. Further side-
by-side comparative studies showed that this dynamic model
generated a tighter barrier function [22]. Additionally, the expres-
sion of transporters, ion channels, and efflux proteins was dra-
matically induced in endothelial cells in this model. Altogether,
these data suggest that this dynamic model better mimics the in
vivo BBB by replicating its anatomic and physiological properties.
This model has been used to study the pathophysiology of various
CNS diseases, including epilepsy [23]. For instance, endothelial
cells and astrocytes from normal or drug-resistant epileptic human
brain tissue have been cultured using this dynamic system. The
permeability to phenytoin, a substrate for P-glycoprotein, was
significantly reduced when endothelial cells from epileptic brain
were used. This effect was independent of the origin of astrocytes
and could be reversed by the P-glycoprotein blocker XR9576,
suggesting that the drug-resistant BBB phenotype in patients with
epilepsy can be replicated using this dynamic BBB model.f central nervous system injury and disease, Drug Discov Today (2016), http://dx.doi.org/
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TABLE 1
Bioengineered systems in CNS research.
Application Concept Materials Cell types Refs
BBB Dynamic culture on porous hollow fibers
using flow to mimic shear stress. Culture
medium is pumped through the hollow
fiber to promote this condition
Polypropylene fibers Endothelial cells and astrocytes
are plated on the inner (luminal)
and outer (abluminal) sides of the
hollow fibers
[21–23]
BBB and
BCSFB
Neurovascular unit on a chip using
microfluidics; comprises three PDMS layers
separated by 0.2-mm pore membranes.
Membranes are bonded between layers to
recreate the microfluidic vasculature and
brain compartments
PDMS (chambers); polycarbonate
(membranes); collagen (biomatrix
for nerve cells to grow in)
Human endothelial cells,
pericytes, astrocytes, and neurons
[24,25]
Mini brain
organoid
Developmental brain model in which high-
density iPSCs are cultured for extended
periods of time to enable the in vitro
development of brain structures
Matrigel iPSCs as a starting point that then
differentiate towards multiple
CNS cell types reconstituting early
phases of brain development,
including formation of brain
barrier-like structures
[34]
CNS niche Establishment of ECM-like hydrogels that
can support the growth of cells relevant for
CNS regeneration
Gellan gum modified with cell
adhesion-related motifs
NSC; olfactory ensheathing cells;
mesenchymal stem cells
[42,43]
Printed 3D cell culture system Thermoresponsive biodegradable
polyurethane bioink
NSC [50]
System that recapitulates CNS niche by
mimicking layer-by-layer organization of
the brain. Based on the combination of
microchambers and biodegradable fibers
Collagen fibers layered on PDMS
microchambers coated with poly-
L-lysine
Matured neurons [63]
Neuronal
networks
3D neural tissue-like structures with fully
matured neuronal networks growing on
hydrogels, interfacing with
microelectrodes for cell stimulation and
environment probing
Hydrogel capable of supporting
neuronal cell growth (e.g.,
collagen, matrigel)
Mature neurons differentiated
from NSC isolated from primary
tissue or differentiated from iPSCs
[44]
Cell growth platforms developed using
NSC and bioactive bioengineered surfaces
obtained by microcontact printing,
piezoelectric spotting of polycationic
biomolecules or ECM on cell-repellent
surfaces
PEO; microelectrode arrays; cell
adhesion peptides (e.g., RGD)
NSC derived from human
umbilical cord mononuclear cells
[45]
Cerebral ischemic
damage
Compartmentalized membrane system
with a sandwich configuration
Fluorocarbon/polyethersulfone
membranes
Neonatal rodent hippocampal
cells and mesenchymal stem cells
[47]
AD Long-term 3D high-density neuronal cell
cultures in matrigel to enable
accumulation of amyloid-b (Ab) and
hyperphosphorylated tau
Matrigel Human neural progenitors [48,49]
SCI In vitro model of SCI that replicates
stereotypical cellular responses to
neurological injury in vivo, including
reactive gliosis, microglial infiltration, and
limited nerve fiber outgrowth. Based on
the combination of organotypical slices
and nanofiber meshes
Polylactic acid nanofiber meshes
coated with laminin
NSC [60]
Modeling isotropic-to-anisotropic cellular
transfections observed in vivo following
spinal cord injury. Comprises the
combination of astrocytes and dissociated
dorsal root ganglia on PLLA fibers and
membranes
Poly-L-lactide (PLLA) fibers and
membranes
Astrocytes and dissociated dorsal
root ganglia
[60]
TBI Long-term 3D-brain-like cortical tissues
based on the combination of cells with 3D
scaffolds and hydrogels subsequently
exposed to a weight drop method injury
Hydrogel (collagen); 3D scaffolds
(silk)
Rodent cortical neurons [64]
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have also been presented. This particular technique has several
advantages, such as the reduction in sample size and compart-
mentalization, which allows an accurate representation of differ-
ent BBB and CNS niches, including the use of dynamic culturing
conditions. The development of a complex ‘neurovascular unit on
a chip’, simultaneously containing features of both the BBB and
the BCSFB, has also been proposed [24]. Recently, the first neuro-
vascular microfluidic reactor was developed and validated; this
platform contains simultaneously human endothelial cells cul-
tured with pericytes, astrocytes, and neurons embedded in extra-
cellular matrix (ECM) components [25]. It comprises two
chambers and three polydimethylsiloxane (PDMS) layers plus
0.2-mm pore polycarbonate membranes between the two cham-
bers. The membrane is bonded between layers of PDMS to create
the microfluidic vasculature and brain compartments. The reactor
also has two perfusion streams, one for the vascular media supply
to the endothelial cells in layer one and another for the brain
media supply to layers two and three, so that one can be used for
the biomatrix (e.g., collagen) and cell loading, and the other for
subsequent perfusion of the brain compartment. The reactor can
be used to recreate important microenvironmental conditions,
including cell/fluid volume ratios, spatial gradients, and proper
fluid flows, which are particularly important for shear stresses
conditions. Thus, this system, and others similar to it, will become
an essential tool for understanding brain barriers under physio-
logical and pathological scenarios, as well as how new drugs can
modulate these barriers.
Developmental disorders
The development of the CNS is a tightly regulated process, and any
interference in it, either from genetic or environmental factors,
can result in severe learning and memory impairments, as well as
motor and sensory dysfunctions [26]. Research on this topic is
currently carried out by using models of developmental diseases,
which can give insights into how a specific condition is established
at the development stage or at a post-onset neurodegenerative
stage, where the goal is to seek ways to potentiate the repair and
regeneration of the damaged tissues or cells. Until a decade ago,
the study of developmental disorders of the CNS was mainly based
on genetic animal models, which, although they have contributed
greatly to the advance of research in this field, they often present a
phenotype that is very different from that of humans as a result of
intraspecies variation [26]. As an alternative, in vitro models were
developed based on neural progenitor cells from postmortem
human neural tissues [27]. However, the access to these tissues
is limited and the lifespan of the cultures is short [26].
With the emergence of human embryonic stem cells (hESCs)
[28] and induced pluripotent stem cells (iPSCs) [29], there was a
major breakthrough in new in vitro models for CNS developmental
disorders. For example, following differentiation protocols, pa-
tient-derived iPSCs can be used as a platform to understand the
molecular mechanisms behind a specific disease. Moreover, iPSC-
derived models can also serve as templates for drug-screening
experiments, as well as other therapeutic strategies. For example,
iPSCs obtained from patients with Costello syndrome (CS) [30]
were differentiated towards a neuroectodermal fate and revealed
an extended progenitor phase compared with controls, whichPlease cite this article in press as: Teixeira, D.T.D. et al. Bioengineered cell culture systems o
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4 www.drugdiscoverytoday.comresulted in an increased production of cortical neurons with
altered neurite length and soma size. These changes have been
described as typical of CS [30]. Another study used PSCs derived
from patients with Down’s syndrome to test chromosome-silenc-
ing therapies [31]. Deficits of proliferation and neural rosette
formation were reversed, which opens a new door for potential
‘chromosome therapy’ techniques. This relatively new field of
science aims, through the use of molecular biology-based techni-
ques, to inactivate the chromosome that has been identified as the
cause for a certain developmental disease (e.g., Down’s syndrome).
iPSC strategies have also been applied to the study of Rett syn-
drome [32] and autism spectrum disorders [33]. Using human
iPSCs, Lancaster and coworkers [34] developed an in vitro brain
model that could be used to mimic different developmental CNS
disorders as well as other brain diseases. The so-called ‘cerebral
organoids’ were capable of forming different interdependent brain
regions, demonstrating several hallmarks of brain development.
However, the main limitation of this model is the lack of a vascular
system for nutrients and oxygen exchange. In a disease context,
this model proved to be useful for the study of microcephaly and
some of its molecular basis. This is of interest given the difficulties
in recapitulating this condition using animal models.
When traumatic injuries occur in the CNS, nervous tissue
damage is usually irreversible. The biological and cellular processes
involved in nerve degeneration are currently not fully understood,
which might be due, in part, to the complexity of the mechanisms
underlying such injuries. Advances in the investigation of in vitro
models of nerve regeneration over the past few years have led to
the development of valuable tools to study the neurobiology and
neuroregeneration of the CNS, with the aim of establishing new
therapies. Recently, CNS models have been developed using
microplatforms that are designed to mimic the dynamics between
several CNS cell types, such as neurons and glia, and the ECM
[35,36]. Microfluidics and biomaterial technologies have been
used to control the physical and chemical cues in such micro-
environments. Microfluidic devices enable a connection to be
formed between different chambers with the controlled insertion
of fluids within it [37]. Such devices allow the study of communi-
cation between different cells and to monitor events such as
axonal migration, synaptic activity, and neuronal networks. These
devices are used to not only study nerve damage at a chemical and
physical level of injury, but also to recreate the postinjury envi-
ronment [35]. Biomaterials are also used to control the in vitro CNS
microenvironment by using several patterning techniques, such as
lithography [38] and electrospinning [39], usually with surface
modifications with ECM-like molecules and synthetic peptides
[40,41] to enhance their bioactivity. For example, Silva et al.
demonstrated that gellan gum-based hydrogels modified with
fibronectin-derived peptides were able to increase both NSC [42]
and bone marrow mesenchymal stem cells (MSCs) [43] metabolic
activity, proliferation, and differentiation. Given that cellular
behavior is highly dependent on the surrounding microenviron-
ment, the presence of biological cues in patterned surfaces are
crucial for cell responsiveness and interaction with the microen-
vironment [40].
Another interesting example of the use of bioengineered sys-
tems is in the study of developmental neurotoxicity (DNT). Mal-
formations and developmental retardation are a major healthf central nervous system injury and disease, Drug Discov Today (2016), http://dx.doi.org/
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chemicals, for which there have been no effective tools of study.
The use of 3D neural tissue-like constructs with fully matured
neuronal networks (derived from NSC obtained from CNS tissue or
from PSCs) growing on hydrogel-based biomaterials, interfacing
with microelectrode arrays for electrical stimulation and response
recording, were proposed as a model of study [44]. In these
systems, the hydrogels act as a surrogate of the ECM found in
vivo. By grafting peptides and/growth factors typical of the ECM of
the cell, it is possible to recapitulate its niche, as well as the
interactions between stem and fully differentiated cells with that
niche. Moreover, hydrogels typically have mechanical properties
similar to those of the CNS ECM, which facilitate cell growth,
migration, and axonal elongation [42,43]. By contrast, during
neuronal differentiation, several parameters, including pH, cell
growth, biomarkers of cell death, or even the establishment of
action potentials, could be screened while the cells are exposed to
toxic compounds, by using the microelectrode systems. These read
outs could then establish a correlation between the conditions
that were tested, their functional outputs, and the possible signal-
ing and/or molecular pathways involved. Buzanska and colleagues
[45] also suggested the use of cell growth platforms based on NSC
and bioactive bioengineered surfaces obtained by microcontact
printing or piezoelectric spotting of polycationic biomolecules
and/or ECM proteins on cell-repellent surfaces. The rationale for
this was to mimic the natural microenvironment of NSCs during
development and predict the action of several compounds on
DNT. Such a system could also be coupled with microelectrode
arrays to determine the functionality of the cells being assessed.
Thus, this multiparametric assessment is an obvious advantage
because information on the sensitivity of certain molecular path-
ways and functional cellular responses to selected neurotoxins can
be rapidly screened.
Neurodegeneration
Neurodegenerative processes within the CNS represent insults
against the homeostasis of the CNS, capable of promoting cell
death in neural populations in the brain and spinal cord [46]. In
recent years, several different bioengineered systems have been
developed to either study degeneration itself or, alternatively,
routes to overcome it either through neuroprotection or neuro-
differentiation-based studies. These systems range from compart-
mentalized chambers, to hydrogel-based biomaterials or even
microfluidics-based approaches.
For instance, Piscioneri et al. [47] described the development
of a compartmentalized membrane system using neonatal ro-
dent hippocampal cells and human MSCs (hMSCs) to investigate
the neuroprotective effects of the latter in a oxygen-glucose
deprivation (OGD) model. The goal was to simulate cerebral
ischemic damage by inducing OGD for 120 min. Cells were
cultured in a membrane system with a sandwich configuration
in which the hippocampal cells were seeded on a fluorocarbon
(FC) membrane, and were separated by hMSCs through a semi-
permeable polyethersulfone (PES) membrane that ensured the
transport of paracrine factors, but prevented cell-to-cell contact.
With this interesting system, the authors were able to show that
the hMSC secretome protected hippocampal cells against the
OGD insult.Please cite this article in press as: Teixeira, D.T.D. et al. Bioengineered cell culture systems o
10.1016/j.drudis.2016.04.020In addition to these systems, recent developments in 3D cellular
culture systems have been made to study the onset of pathogenesis
and early development of a disease. Kim and colleagues [48]
recently developed the first human 3D cellular culture system
through the use of human neural progenitors (hNPCs), able to
recreate the key events of AD pathogenesis, such as the accumula-
tion of amyloid-b (Ab) and hyperphosphorylated tau. In this
particular system, hNPCs that produce high concentrations of
pathogenic Ab species are combined with a Matrigel-based 3D
culture system, providing an environment that favors Ab deposi-
tion. According to the authors, the culture system takes 1–2 days to
establish, while Ab is formed after 6 weeks of differentiation and
Tau-related pathology after 10–14 weeks. This kind of approach
could provide a flexible scalability that could make it an ideal
model for application to other neurodegenerative disorders (e.g.,
PD), being not only suitable for the study of diseases characterized
by abnormal aggregation of misfolded proteins, but also for new
diagnostic and/or prognostic biomarkers, large-scale testing, and
drug screenings [48,49].
Finally, by using 3D bioprinting, Hsiesh and Hsu [50] embedded
NSCs in a thermoresponsive biodegradable polyurethane (PU)
bioink, creating a printed 3D cell culture system with robust levels
of viability and differentiation after printing that could be further
used in the context of neurodegenerative disease. Low-cost 3D
printed devices have also been developed for growing and imaging
primary neuronal cultures, revealing the multiple uses of this
technology [51]. Indeed, 3D printing techniques could represent
a fast and reliable method for the establishment of 3D organoid-
based models for CNS research [52,53]. Cell and/or biomaterial
constructs with a layer-by-layer architecture enable the separation
of different cell types that can still interact via paracrine action,
mimicking, for instance, some of the phenomena seen in brain
barriers or trauma-related conditions. Additionally, each of these
layers can have its own specific properties (e.g., ECM motifs,
rigidity, or diffusion) enabling from the very beginning (because
the system allows cells to be embedded while biomaterials are
being printed) the creation of different subniches under the same
cell culture setup paradigm. Finally, although these models do
currently represent an additional cost compared with standard 2D
cell-based models, the outputs obtained from them, as well as their
proximity to in vivo environments, make them viable for the
applications discussed here. Moreover, it is also expected that
the costs associated will decrease with the further development
of the technology.
Trauma
SCI and TBI are leading causes of death and disabilities worldwide
[48,54]. These injuries are usually caused by external physical
insults, most frequently as a result of impact, such as contusion
and compression, or due to laceration, resulting in severe func-
tional disabilities [54]. Subsequent to the initial trauma, a well-
characterized cascade of events, including necrosis, hemorrhage,
oxidative stress, excitotoxicity, inflammation, cavity formation
(e.g., spinal cord), and astrogliosis, occurs in both SCI and TBI that
further compromises neurologic function.
In vitro models of trauma in the CNS are obtained using different
mechanical stimuli, either by using basic 2D or more complex 3D
culture systems. The most common are transection (by laceratingf central nervous system injury and disease, Drug Discov Today (2016), http://dx.doi.org/
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FIGURE 1
Schematic representation of traumatic brain injury (TBI) and spinal cord injury (SCI) in vitro models (a) SCI 2D in vitro model from spinal cord embryo cells. After
cutting the monolayer, an initial cell-free area appears, accompanied over time by many features of SCI [58]. (b) In vitro production and lesioning of organotypic
spinal cord slice cultures [59]. (c) Sterilized poly-L-lactide (PLLA) fiber scaffolds coated with fibronectin are used to culture both neurons and astrocytes, forming a
neuronal 3D in vitro model [60]. (d) Schematic representation of each stage of the culture system methods to obtain a 3D in vitro cerebral-like tissue [34]. (e)
Design concept of an in vitro cortical tissue. The material design of the scaffold composite supports the 3D axon connections. The resulting module comprises two
regions: neuron-rich gray matter and axon-only matter [64]. (f) Bioprinting: imaging and assessment of the damaged tissue and its environment are first
performed, and then the most suitable material and cell type are selected [52]. Both cells and material can be plotted at same time using new rapid prototyping
equipment. Some tissues require a period of maturation in a bioreactor before transplantation.
R
eview
s
P
O
S
T
S
C
R
E
E
Nor cutting axons in primary neuronal or organotypical cultures) or
compression (mechanical damage, usually by manually crushing
CNS structures, commonly in organotypical cultures). Other sys-
tems try to tackle more complex insults, such as drastic accelera-
tion and deceleration processes, which can cause, for instance,
diffuse axonal injury or barotrauma, which can result from pres-
sure waves that propagate through the intracranial and/or spinal
contents as a consequence of trauma.
Injury to 2D cultures can be achieved by applying one or more
injury-related stimuli [55]. For example, Jowers used a scratch-
induced method of injury to model TBI, whereas Salvador and
colleagues used stretch injury in combination with OGD to mimic
ischemic events that occur after TBI [56,57]. By contrast, to create a
SCI in vitro model, Boomkamp and colleagues cultured dissociated
rat embryonic spinal cord cells plated onto a monolayer of astro-
cytes. After cutting the cultures, an initial cell-free area appeared
devoid of neurites, accompanied over time by many features of
SCI, including demyelination, reduced neurite density adjacent to
the lesion, and infiltration of microglia and reactive astrocytes into
the lesioned area. The pharmacological manipulation of this
system using Rho and ROCK inhibitors revealed that both neuritePlease cite this article in press as: Teixeira, D.T.D. et al. Bioengineered cell culture systems o
10.1016/j.drudis.2016.04.020
6 www.drugdiscoverytoday.comextension and myelination could be observed in the initial cell-
free area, showing the validity of the model as a tool to predict
axonal growth in a SCI-like environment. (Fig. 1a) [58].
2D in vitro cultures of neuronal cells offer simplified high-
throughput systems. However, they lack endogenous 3D cell–cell
interactions and physiological cues provided by the ECM. Thus,
organotypic experimental preparations, such as brain and spinal
cord slices, have been used as tools to develop bioengineered
systems in combination with biomaterials. An interesting ex vivo
SCI model using longitudinal spinal cord sections (Fig. 1b) was
developed by Weightman and colleagues to test the viability of
biomaterial platforms allowing high-throughput screening of neu-
roregenerative biomaterials [59]. In turn, biomaterials can also be
used to model the injury site. Recently, an in vitro culture system
using patterned electrospun fibers of poly-L-lactic acid and smooth
films was developed to study how astrocytes respond to local
changes in surface topography that might be similar to topograph-
ical changes following SCI (Fig. 1c) [60].
The previously referred to organoid-based culture systems could
also become valuable tools for SCI and TBI research (Fig. 1d).
However, these systems have limitations, such as the degree off central nervous system injury and disease, Drug Discov Today (2016), http://dx.doi.org/
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Nmaturation and absence of a vascular system [34,61]. Indeed, the
vascular system is important under the context of a trauma-based
response following CNS injury. Through the reorganization of the
vasculature and angiogenesis, both oxygen and growth factor
gradients can be established, leading to chemotactic responses
by host cells involved in key processes, such as cell survival,
differentiation, and inflammation. For instance, Duah and collea-
gues recently showed how angiogenesis could be related to the
improved functionality of a rat SCI animal model, as a response to
a neurotrophin-3 (NT-3)-based therapy [62].
Similarly to other conditions, tissue-engineered constructs can
also be used for CNS trauma-related studies. Odawara and colleagues
developed 3D neuronal networks with a layered structure using
collagen fibers and polydimethylsiloxane microchambers [63].
Tang-Schomer and colleagues went a step further in developing
functional, long-term viable, 3D brain-like cortical tissues, with gray
and white matter compartmentalization and electrophysiological
function using silk protein-based scaffolds combined with a colla-
gen gel (Fig. 1e). When a weight drop injury model was used, the
tissue exhibited injury-induced glutamate release and transient
electrical hyperactivity, recapitulating the in vivo pathophysiology
of TBI [64].
Concluding remarks
Since their initial development at the start of the 20th century, cell
culture systems have enabled scientists to better understand the
physiology, biochemistry, and molecular mechanisms of almostPlease cite this article in press as: Teixeira, D.T.D. et al. Bioengineered cell culture systems o
10.1016/j.drudis.2016.04.020all organs and systems within the human body, including the CNS.
Given that the limitations of standard 2D cell cultures techniques
were reached several years ago, bioengineered 3D systems are
presented as the alternative for the further development of this
technical field. With a multiparameter analysis always present,
these systems, based on hydrogels, membranes, microfluidics,
stem cells, and microelectrode arrays, enable researchers to not
only culture cells in environments that mimic the different CNS
niches, but also obtain important data on the functionality of the
CNS cells that are being used. However, such systems still have
several disadvantages, particularly their complexity, which usually
demands specific expertise, and the cost, which is currently sig-
nificantly higher compared with standard 2D systems. Neverthe-
less, their potential is high and, therefore, they should be
considered as the future of in vitro studies in CNS research.
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